Home / Recalls / Tris Pharma Inc. / D-0495-2019

D-0495-2019 Class II Terminated

Recalled by Tris Pharma Inc. — Monmouth Junction, NJ

Recall Details

Product Type
Drugs
Report Date
February 20, 2019
Initiation Date
January 15, 2019
Termination Date
March 29, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
35,280 bottles

Product Description

Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Berry Flavor, 1 FL OZ (30 mL) bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 39961 3, NDC 50428-1252-4.

Reason for Recall

Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

Distribution Pattern

One distributor who further distributed Nationwide in the USA.

Code Information

Lot#: 00717006A, Exp 02/19

Other recalls by Tris Pharma Inc.

  • D-1517-2019 Class II — Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspensi (July 11, 2019)
  • D-0493-2019 Class II — Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg (January 15, 2019)
  • D-0494-2019 Class II — infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg p (January 15, 2019)
  • D-0337-2019 Class II — Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg (November 26, 2018)
  • D-0336-2019 Class II — Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg (November 26, 2018)
  • D-0335-2019 Class II — infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg p (November 26, 2018)
  • D-1126-2017 Class II — Morphine Sulfate Oral Solution, 100 mg/ 5 mL (20 mg/mL), packaged in a 1 oz. bot (June 15, 2017)